Addiction Institute of Mount Sinai

Medicine & Life Sciences

1. Nucleus Accumbens 100%
2. Cocaine 91%
3. Brain 86%
4. Reward 79%
5. Alzheimer Disease 69%
6. Substance-Related Disorders 66%
7. Depression 52%
8. Neurons 51%
9. Epigenomics 49%
10. Opioid Analgesics 45%
11. Opioid Receptors 40%
12. Pharmaceutical Preparations 39%
13. Prefrontal Cortex 37%
14. Ventral Tegmental Area 35%
15. Genes 35%
16. Schizophrenia 31%
17. Psychotic Disorders 30%
18. Morphine 28%
19. Cannabis 27%
20. G-Protein-Coupled Receptors 26%
21. Genome-Wide Association Study 25%
22. Dopamine 25%
23. Gene Expression 24%
24. Antidepressive Agents 24%
25. Therapeutics 23%
26. Anxiety 22%
27. Alcoholism 22%
28. Mental Disorders 22%
29. Histones 22%
30. Corpus Striatum 22%
31. Cocaine-Related Disorders 21%
32. Psychiatry 21%
33. Neuronal Plasticity 21%
34. Chromatin 20%
35. Feeding and Eating Disorders 18%
36. Cues 18%
37. Suicide 18%
38. Major Depressive Disorder 17%
39. Dopaminergic Neurons 17%
40. Attention Deficit Disorder with Hyperactivity 17%
41. HIV 17%
42. Genome 16%
43. Heroin 16%
44. Magnetic Resonance Imaging 16%
45. Brain-Derived Neurotrophic Factor 16%
46. Psychological Inhibition 16%
47. Craving 15%
48. Dronabinol 15%
49. Cannabinoids 15%
50. Optogenetics 15%
51. Alcohols 15%
52. Proteins 14%
53. Peptides 14%
54. Rodentia 14%
55. Cognition 14%
56. Synapses 14%
57. Nicotine 14%
58. Anorexia Nervosa 14%
59. Cannabinoid Receptors 14%
60. Phenotype 13%
61. Neuralgia 13%
62. Self Administration 13%
63. Hepacivirus 13%
64. Amygdala 13%
65. Habenula 13%
66. Neurobiology 13%
67. GTP-Binding Proteins 13%
68. Animal Models 13%
69. Pain 13%
70. Hospital Emergency Service 12%
71. Opioid-Related Disorders 12%
72. Cannabidiol 12%
73. GTP-Binding Protein Regulators 12%
74. Meta-Analysis 12%
75. Single Nucleotide Polymorphism 12%
76. Neuroimaging 12%
77. Emotions 12%
78. Aggression 12%
79. Population 12%
80. Motivation 11%
81. Pharmacology 11%
82. Pathology 11%
83. Transcription Factors 11%
84. Hepatitis C 11%
85. Mutation 11%
86. Ligands 11%
87. Opiate Alkaloids 11%
88. Memory 11%
89. mu Opioid Receptor 11%
90. Neuropeptides 11%
91. Drug Overdose 11%
92. Cognitive Dysfunction 10%
93. Microglia 10%
94. Chronic Pain 10%
95. DNA Methylation 10%
96. MicroRNAs 10%
97. Performance-Enhancing Substances 10%
98. Sex Characteristics 10%
99. Hippocampus 10%
100. Biomarkers 10%